Zachary Frosch, MD, MSHP

Assistant Professor, Department of Hematology/Oncology

Specialties

Hematology Oncology

Areas of Expertise

Lymphoma, Leukemia

Treatment Focus

Hodgkin's and Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia

Research Program

Cancer Prevention and Control

Treatment Philosophy

Receiving a cancer diagnosis and starting treatment can be overwhelming. Guiding patients through this difficult process is what first drew me to oncology. I work to help my patients understand their cancer and the different ways we can treat it. I also have a focus on teaching and education, which informs how I approach each conversation with my patients.

In addition to caring for patients, I conduct research in cancer care delivery, aiming to make the process of receiving cancer care simpler, faster, and more accessible to our patients.

Lab Overview

My research focuses on cancer care delivery. This work aims to make the process of receiving cancer care simpler, faster, and more accessible to patients. Recently, I have focused on two key areas: facilitating timely access to cancer treatment, and reducing disparities in the use of specialized therapies that are only available at certain cancer centers. My research is collaborative and draws on techniques from multiple disciplines. These include the analysis of cancer registry and electronic health record data, surveys, qualitative interviews, predictive analytics, and implementation science.

Clinical Locations

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427

Educational Background

2019-2021 - MS, Health Policy Research, Perelman School of Medicine, University of Pennsylvania
2010-2014 - MD, Perelman School of Medicine, University of Pennsylvania
2004-2008 - BA, Wesleyan University

Certifications

American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Medical Oncology

Memberships

2013-Present - American Society of Hematology
2017-Present - American Society of Clinical Oncology

Honors & Awards

2021 - American Society of Clinical Oncology/Conquer Cancer Foundation Young Investigator Award
2020 - American Society of Clinical Oncology/Conquer Cancer Foundation Merit Award
2017 - American Society of Clinical Oncology/Conquer Cancer Foundation Merit Award
2016 - Martin P. Solomon Primary Care Scholarship Award, Brigham and Women’s Hospital
2013 - American Society of Hematology Abstract Achievement Award
2008 - Walkley Prize for Outstanding Research in Psychology at Wesleyan University
2008 - Graham Prize for Excellence in the Natural Sciences at Wesleyan University

Research Interests

Health services research
Cancer care delivery
Access to cancer treatment and cancer care disparities

Selected Publications

Frosch ZAK, Namoglu EC, Mitra N et al. Willingness to travel for cellular therapy: the influence of follow-up care location, oncologist continuity and race. JCO Oncology Practice. 2021; OP2100312.

Fang CY and Frosch ZAK. Understanding and Addressing Cancer Care Costs in the United States. JAMA Netw Open. 2021; 4(10):e2127964.

Frosch ZAKF, Illenberger N, Mitra N et al. Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation. JAMA Netw Open. 2021.

Hawrot K, Shulman LN, Bleiweiss IJ, Wilkie EJ, Frosch ZAK, Jankowitz RC, Laughlin AI. Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic. JCO Oncol Pract. 2021 Mar 12;:OP2000807. doi: 10.1200/OP.20.00807. [Epub ahead of print] PubMed PMID: 33710914.

Frosch ZAK, Shulman LN, Bekelman JE. Independent Oncology Practices in the COVID-19 Era-Does US Cancer Care Need a Bailout?. JAMA Oncol.2021 Mar 1;7(3):347-348. doi: 10.1001/jamaoncol.2020.4753. PubMed PMID: 33090180.

Frosch ZAK, Landsburg DJ. Molecular Risk Stratification in Aggressive B-Cell Lymphomas. J Clin Oncol. 2020 Jun 20;38(18):2014-2017. doi: 10.1200/JCO.19.03069. Epub 2020 Apr 2. PubMed PMID: 32243222; PubMed Central PMCID: PMC7302956.

Frosch ZAK, Cronin AM, Gagne JJ, Teschke MP, Gray SW, Abel GA. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population. Cancer. 2018 May 15;124(10):2205-2211. doi: 10.1002/cncr.31246. Epub 2018 Apr 8. PubMed PMID: 29635808.

Frosch ZAK, Gagne JJ, Gray SW, Abel GA. What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment. J Oncol Pract. 2018 Mar;14(3):139-140. doi: 10.1200/JOP.17.00009. Epub 2018 Jan 30. PubMed PMID: 29381410.

Frosch ZA, Abel GA. Assessing Quality of Care for the Myelodysplastic Syndromes. Curr Hematol Malig Rep. 2016 Dec;11(6):402-407. doi: 10.1007/s11899-016-0343-0. Review. PubMed PMID: 27562670.

Frosch Z, Luskin MR, Landsburg DJ, Schuster SJ, Svoboda J, Loren AW, Porter DL, Stadtmauer EA, Nasta SD. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):92-7. doi: 10.1016/j.clml.2014.07.017. Epub 2014 Aug 1. PubMed PMID: 25174772.

Additional Publications

MyNCBI

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.